https://www.curevac.com/history/gruendung-am-4-februar-2000/ 2021-04-25T15:57:21+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-07.jpg https://www.curevac.com/history/zulassung-fuer-weltweit-erste-gmp-produktionsanlage/ 2021-04-25T15:57:27+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-technologiepark.jpg https://www.curevac.com/history/gruendung-einer-us-niederlassung-in-boston/ 2021-04-25T15:58:28+00:00 https://www.curevac.com/wp-content/uploads/2020/06/artem-sapegin-PoHAyYLpkOM-unsplash-scaled.jpg https://www.curevac.com/history/erweiterung-des-europaeischen-netzwerks-zur-impfstoffherstellung-mit-partnern/ 2021-04-25T16:00:25+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-europe-network.jpg https://www.curevac.com/history/kooperation-mit-bayer/ 2021-04-25T16:00:29+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-22.png https://www.curevac.com/history/kooperation-mit-britischer-regierung-zur-entwicklung-von-impfstoffen-gegen-sars-cov-2-varianten/ 2021-04-25T16:00:35+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-hm-goverment.png https://www.curevac.com/history/neue-kooperation-mit-gsk-zur-entwicklung-von-impfstoffen-der-neuen-generation/ 2021-04-25T16:01:00+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-gsk.jpg https://www.curevac.com/history/investment-der-bill-melinda-gates-foundation/ 2021-04-26T11:05:28+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-gatesfoundation.png https://www.curevac.com/history/herstellungsvereinbarung-mit-novartis/ 2021-04-26T11:06:17+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-sandoz.jpg https://www.curevac.com/history/weltweit-erste-klinische-studie-mit-mrna-basiertem-impfstoff-gegen-tollwut/ 2021-05-28T18:08:42+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-14.jpg https://www.curevac.com/history/beginn-der-phase-1-studie-fuer-covid-19-impfstoff-kandidaten/ 2021-05-28T18:14:07+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-16.jpg https://www.curevac.com/history/start-des-rollierenden-zulassungsverfahrens-fuer-covid-19-impfstoff-kandidaten/ 2021-05-28T18:22:18+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-historie-35.jpg https://www.curevac.com/history/entwicklung-der-rna-als-vakzin/ 2021-05-28T18:46:42+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-09.jpg https://www.curevac.com/en/history/development-of-rna-as-vaccine/ 2021-05-28T18:51:56+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-09.jpg https://www.curevac.com/en/history/foundation-on-februar-4-2000/ 2021-05-28T18:55:16+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-07.jpg https://www.curevac.com/en/history/approval-for-worlds-first-gmp-compliant-production-facility/ 2021-05-28T18:56:01+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-technologiepark.jpg https://www.curevac.com/history/investment-durch-dievini-hopp-biotech-von-dietmar-hopp/ 2021-05-28T18:56:21+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-01.jpg https://www.curevac.com/en/history/investment-by-dievini-hopp-biotech-von-dietmar-hopp/ 2021-05-28T18:56:49+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-01.jpg https://www.curevac.com/history/erste-klinische-studie-in-der-onkologie/ 2021-05-28T18:57:12+00:00 https://www.curevac.com/wp-content/uploads/2020/08/curevac-header-image-22-scaled.jpg https://www.curevac.com/en/history/first-clinical-study-in-oncology/ 2021-05-28T18:57:27+00:00 https://www.curevac.com/wp-content/uploads/2020/08/curevac-header-image-22-scaled.jpg https://www.curevac.com/en/history/worlds-first-clinical-trial-with-mrna-based-rabies-vaccine/ 2021-05-28T18:58:32+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-14.jpg https://www.curevac.com/en/history/investment-of-the-bill-melinda-gates-foundation/ 2021-05-28T18:59:56+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-gatesfoundation.png https://www.curevac.com/en/history/subsidiary-in-boston-massachusetts-usa/ 2021-05-28T19:00:49+00:00 https://www.curevac.com/wp-content/uploads/2020/06/artem-sapegin-PoHAyYLpkOM-unsplash-scaled.jpg https://www.curevac.com/history/grundsteinlegung-fuer-neues-labor-und-forschungsgebaeude-fuer-mrna-wirkstoffe/ 2021-05-28T19:01:15+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-03.jpg https://www.curevac.com/en/history/foundation-stone-laid-for-new-laboratory-and-research-building/ 2021-05-28T19:01:35+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-03.jpg https://www.curevac.com/history/erster-prototyp-des-the-rna-printer/ 2021-05-28T19:02:00+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-17.jpg https://www.curevac.com/en/history/first-prototype-of-the-rna-printer/ 2021-05-28T19:02:15+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-17.jpg https://www.curevac.com/en/history/start-of-phase-1-trial-of-covid-19-vaccine-candidate/ 2021-05-28T19:03:36+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-16.jpg https://www.curevac.com/history/nasdaq-boersengang/ 2021-05-28T19:04:00+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-nasdaq.jpg https://www.curevac.com/en/history/nasdaq-ipo/ 2021-05-28T19:04:19+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-nasdaq.jpg https://www.curevac.com/en/history/start-of-pivotal-phase-study-for-covid-19-vaccine-candidate/ 2021-05-28T19:05:02+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-vaccination.jpg https://www.curevac.com/history/start-of-pivotal-phase-study-for-covid-19-vaccine-candidate/ 2021-05-28T19:05:02+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-vaccination.jpg https://www.curevac.com/en/history/expanding-network-for-vaccine-manufacturing/ 2021-05-28T19:05:31+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-europe-network.jpg https://www.curevac.com/en/history/partnership-with-bayer/ 2021-05-28T19:06:04+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-22.png https://www.curevac.com/en/history/collaboration-with-gsk-for-development-of-next-generation-vaccines/ 2021-05-28T19:09:27+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-gsk.jpg https://www.curevac.com/en/history/collaboration-with-uk-government-for-development-of-vaccines-against-sars-cov-2-variants/ 2021-05-28T19:09:42+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-hm-goverment.png https://www.curevac.com/en/history/start-of-rolling-submission-for-covid-19-vaccine-candidate/ 2021-05-28T19:09:57+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-historie-35.jpg https://www.curevac.com/en/history/manufacturing-agreement-with-novartis/ 2021-05-28T19:10:09+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-history-sandoz.jpg https://www.curevac.com/history/herstellungserlaubnis-fuer-gmp-iii-produktionsanlage/ 2021-06-20T12:37:23+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-historie-36.jpg https://www.curevac.com/en/history/manufacturing-permit-for-its-gmp-iii-production-facility/ 2021-06-20T12:37:42+00:00 https://www.curevac.com/wp-content/uploads/2021/03/curevac-historie-36.jpg